胺碘酮联合厄贝沙坦治疗心力衰竭合并心律失常的疗效及对心功能的影响分析
|
摘要
目的探索胺碘酮与厄贝沙坦联合治疗心力衰竭合并心律失常的临床效果以及心功能影响。方法选择我院就诊的心力衰竭合并心律失常患者作为探究对象(例数:100例;时间:2017.2.22-2018.1.23),实施信封随机分组模式进行分组,50例/组,分别给予胺碘酮、胺碘酮联合厄贝沙坦治疗,比较2组治疗效果、心功能指标情况、不良反应发生情况、血压数据、心率。结果观察组治疗效果高于对照组,心功能指标、血压数据、心率优于对照组,不良反应发生例数低于对照组,P<0.05。结论胺碘酮与厄贝沙坦联合治疗心力衰竭合并心律失常效果显著,可有效改善患者心功能指标情况,安全有效,可推广。
Objective To explore the clinical effects of amiodarone combined with irbesartan in the treatment of heart failure with arrhythmia and the effects of cardiac function.Methods Patients with heart failure and arrhythmia who were treated in our hospital were selected as the target of investigation(number of cases:100 cases;time:2017.2.22-2018.1.23).Envelope random grouping mode was implemented for grouping,50 cases/group,respectively.Ketone,amiodarone and irbesartan were used to compare the effects of treatment,cardiac function,adverse reactions,blood pressure data and heart rate.Results The therapeutic effect of the observation group was higher than that of the control group.The cardiac function index,blood pressure data and heart rate were better than the control group.The number of adverse reactions was lower than that of the control group,P<0.05.Conclusion Amiodarone combined with irbesartan is effective in the treatment of heart failure with arrhythmia,which can effectively improve the cardiac function of patients,safe and effective,and can be promoted.
Objective To explore the clinical effects of amiodarone combined with irbesartan in the treatment of heart failure with arrhythmia and the effects of cardiac function.Methods Patients with heart failure and arrhythmia who were treated in our hospital were selected as the target of investigation(number of cases:100 cases;time:2017.2.22-2018.1.23).Envelope random grouping mode was implemented for grouping,50 cases/group,respectively.Ketone,amiodarone and irbesartan were used to compare the effects of treatment,cardiac function,adverse reactions,blood pressure data and heart rate.Results The therapeutic effect of the observation group was higher than that of the control group.The cardiac function index,blood pressure data and heart rate were better than the control group.The number of adverse reactions was lower than that of the control group,P<0.05.Conclusion Amiodarone combined with irbesartan is effective in the treatment of heart failure with arrhythmia,which can effectively improve the cardiac function of patients,safe and effective,and can be promoted.
引文
[1] 林青,刘宝宏,吴献豪,等.厄贝沙坦联合胺碘酮在心力衰竭合并心律失常患者中的治疗效果及对心功能的影响[J].中国循证心血管医学杂志,2017,9(6):732-733.
[2] 王粉鱼.胺碘酮对老年慢性心力衰竭合并心律失常患者治疗效果研究[J].中国药物与临床,2016,16(4):569-570.
[3] 姚宇彤.胺碘酮治疗心力衰竭合并心律失常患者的临床护理观察[J].中国药物与临床,2016,16(3):445-447.
[4] 梁蕴瑜,姚晓彬.稳心颗粒联合胺碘酮治疗心力衰竭合并心律失常的Meta分析[J].中西医结合心脑血管病杂志,2017,15(16):2006-2009.
[5] 白润爱,何勇.胺碘酮联合厄贝沙坦对充血性心力衰竭并室性心律失常的疗效观察[J].中国循证心血管医学杂志,2016,8(2):180-182.
[6] 张芳,黄东博,解卫春,等.胺碘酮联合厄贝沙坦对慢性心功能不全合并阵发性房颤的临床效果观察[J].现代生物医学进展,2013,13(18):3538-3541.
[7] 梁蕴瑜,姚晓彬.稳心颗粒联合胺碘酮治疗心力衰竭合并心律失常的Meta分析[J].中西医结合心脑血管病杂志,2017,15(16):2006-2009.
[8] 郑宏健,祝长芝.厄贝沙坦联合胺碘酮对慢性心力衰竭患者P波离散度与阵发性心房颤动的影响[J].心脑血管病防治,2017,17(3):182-184.
[9] 汤诺,陈成,曲畅,等.复律宁颗粒辅助治疗气阴两亏型慢性心力衰竭合并心律失常30例临床观察[J].中医杂志,2015,56(18):1564-1568.
[10] 魏娜,曲畅,汤诺,等.复律宁颗粒联合西药治疗气阴两虚型慢性心力衰竭合并心律失常40例临床观察[J].中医杂志,2017,58(21):1833-1837.
[11] 李海嵘,陈关良,方小丽,等.参松养心胶囊对慢性心力衰竭合并室性心律失常患者血流动力学的影响研究[J].重庆医学,2017,46(33):4647-4649.
[12] 相仕涛,李玉龙,龙朋伟.心力衰竭合并心律失常的药物治疗进展[J].中国临床保健杂志,2016,19(6):660-662.
[13] 姚朱华,陈湾湾,曹明英,等.注射用重组人尿激酶原治疗急性 ST段抬高型心肌梗死的疗效和安全性及影响因素分析[J].中国全科医学,2016,19(9):1061-1066.
[14] 马文韬,赵爽,樊晓寒,等.影响心房颤动合并心力衰竭患者预后的危险因素[J].中华心律失常学杂志,2016,20(3):224-228.
[15] 曾光豪,金杰,彭沪.不同剂量左西孟旦对慢性心力衰竭患者影响的对比研究[J].实用心脑肺血管病杂志,2017,25(7):62-65.
[2] 王粉鱼.胺碘酮对老年慢性心力衰竭合并心律失常患者治疗效果研究[J].中国药物与临床,2016,16(4):569-570.
[3] 姚宇彤.胺碘酮治疗心力衰竭合并心律失常患者的临床护理观察[J].中国药物与临床,2016,16(3):445-447.
[4] 梁蕴瑜,姚晓彬.稳心颗粒联合胺碘酮治疗心力衰竭合并心律失常的Meta分析[J].中西医结合心脑血管病杂志,2017,15(16):2006-2009.
[5] 白润爱,何勇.胺碘酮联合厄贝沙坦对充血性心力衰竭并室性心律失常的疗效观察[J].中国循证心血管医学杂志,2016,8(2):180-182.
[6] 张芳,黄东博,解卫春,等.胺碘酮联合厄贝沙坦对慢性心功能不全合并阵发性房颤的临床效果观察[J].现代生物医学进展,2013,13(18):3538-3541.
[7] 梁蕴瑜,姚晓彬.稳心颗粒联合胺碘酮治疗心力衰竭合并心律失常的Meta分析[J].中西医结合心脑血管病杂志,2017,15(16):2006-2009.
[8] 郑宏健,祝长芝.厄贝沙坦联合胺碘酮对慢性心力衰竭患者P波离散度与阵发性心房颤动的影响[J].心脑血管病防治,2017,17(3):182-184.
[9] 汤诺,陈成,曲畅,等.复律宁颗粒辅助治疗气阴两亏型慢性心力衰竭合并心律失常30例临床观察[J].中医杂志,2015,56(18):1564-1568.
[10] 魏娜,曲畅,汤诺,等.复律宁颗粒联合西药治疗气阴两虚型慢性心力衰竭合并心律失常40例临床观察[J].中医杂志,2017,58(21):1833-1837.
[11] 李海嵘,陈关良,方小丽,等.参松养心胶囊对慢性心力衰竭合并室性心律失常患者血流动力学的影响研究[J].重庆医学,2017,46(33):4647-4649.
[12] 相仕涛,李玉龙,龙朋伟.心力衰竭合并心律失常的药物治疗进展[J].中国临床保健杂志,2016,19(6):660-662.
[13] 姚朱华,陈湾湾,曹明英,等.注射用重组人尿激酶原治疗急性 ST段抬高型心肌梗死的疗效和安全性及影响因素分析[J].中国全科医学,2016,19(9):1061-1066.
[14] 马文韬,赵爽,樊晓寒,等.影响心房颤动合并心力衰竭患者预后的危险因素[J].中华心律失常学杂志,2016,20(3):224-228.
[15] 曾光豪,金杰,彭沪.不同剂量左西孟旦对慢性心力衰竭患者影响的对比研究[J].实用心脑肺血管病杂志,2017,25(7):62-65.